MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/aji.13668

Медицинская библиотека · American journal of reproductive immunology (New York, N.Y. : 1989) · 2022

Primary oral vaccination followed by a vaginal pull protects mice against genital HSV-2 infection.

Mulvey Peter B M, Trim Logan K, Aaskov John G, Bryan Emily R, Sweeney Emma L, Kollipara Avinash, Plenderleith Mark B, Aldwell Frank E, Beagley Kenneth W

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

PROBLEM: HSV-2 infected more than 491 million people aged 15-49 world-wide in 2016. The morbidity associated with recurrent infections and the increased risk of HIV infection make this a major health problem. To date there is no effective vaccine. Because HSV-2 ascends to the dorsal route ganglion within 12-18 h of infection, an effective vaccine will need to elicit a strong local resident CD8+ T cell response to prevent the infection from becoming life-long.

METHOD OF STUDY: Using a mouse model we investigated the potential of oral immunization with a novel lipid adjuvant (LiporaleTM ) followed by local vaginal application of an inflammatory agents to protect against primary HSV-2 infections.

RESULTS

Oral vaccination of mice with live-attenuated HSV-2 in Liporale followed by vaginal application of DNFB or CXCL9/10 led to recruitment of tissue-resident CD8+ memory cells into the genital epithelia. This prime and pull vaccination strategy provided complete protection against wild-type HSV-2 challenge and prevented viral dissemination to the spinal cords.

CONCLUSIONS

Activation of mucosal immunity by oral immunization, combined with induction of transient local genital inflammation can recruit long-lived tissue resident CD8+ T cells into the genital epithelium, providing significant protection against primary HSV-2 infection.

Для цитирования: Mulvey Peter B M, Trim Logan K, Aaskov John G, Bryan Emily R, Sweeney Emma L, Kollipara Avinash, Plenderleith Mark B, Aldwell Frank E, Beagley Kenneth W. Primary oral vaccination followed by a vaginal pull protects mice against genital HSV-2 infection.. American journal of reproductive immunology (New York, N.Y. : 1989). 2022. DOI: 10.1111/aji.13668.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.